Chinook Therapeutics Inc
|Market Cap (Intraday)||1.46B|
|2yr Forward PE||N/A|
Chinook Therapeutics Inc Stock, NASDAQ:KDNY
Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in discovering, developing, and commercializing precision medicines for rare, severe chronic kidney diseases. The company was founded in 2019 and is headquartered in Seattle, WA.